MwanzoHKMPF • OTCMKTS
add
Hikma Pharmaceuticals Plc
Bei iliyotangulia
$ 22.56
Bei za mwaka
$ 21.90 - $ 26.50
Thamani ya kampuni katika soko
4.33B GBP
Wastani wa hisa zilizouzwa
28.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
LON
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 784.50M | 9.95% |
Matumizi ya uendeshaji wa biashara | 177.00M | -12.81% |
Mapato halisi | 113.00M | 72.52% |
Kiwango cha faida halisi | 14.40 | 56.86% |
Mapato kwa kila hisa | — | — |
EBITDA | 249.50M | 11.88% |
Asilimia ya kodi ya mapato | 20.49% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 260.00M | -11.56% |
Jumla ya mali | 4.85B | 4.94% |
Jumla ya dhima | 2.55B | 5.38% |
Jumla ya hisa | 2.30B | — |
hisa zilizosalia | 221.75M | — |
Uwiano wa bei na thamani | 2.19 | — |
Faida inayotokana na mali | 10.37% | — |
Faida inayotokana mtaji | 14.05% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 113.00M | 72.52% |
Pesa kutokana na shughuli | 99.00M | -10.81% |
Pesa kutokana na uwekezaji | -53.00M | 10.92% |
Pesa kutokana na ufadhili | -26.00M | 46.94% |
Mabadiliko halisi ya pesa taslimu | 15.50M | 1,450.00% |
Mtiririko huru wa pesa | 116.38M | 10.50% |
Kuhusu
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Ilianzishwa
1978
Tovuti
Wafanyakazi
9,100
